FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2806193092> ?p ?o ?g. }

• W2806193092 endingPage "933" @default.
• W2806193092 startingPage "921" @default.
• W2806193092 abstract "Head and neck squamous cell carcinoma (HNSCC) currently only has one FDA-approved cancer intrinsic targeted therapy, the epidermal growth factor receptor (EGFR) inhibitor cetuximab, to which only approximately 10% of tumors are sensitive. In order to extend therapy options, we subjected patient-derived HNSCC cells to small-molecule inhibitor and siRNA screens, first, to find effective combination therapies with an EGFR inhibitor, and second, to determine a potential mechanistic basis for repurposing the FDA approved agents for HNSCC. The combinations of EGFR inhibitor with anaplastic lymphoma kinase (ALK) inhibitors demonstrated synergy at the highest ratio in our cohort, 4/8 HNSCC patients' derived tumor cells, and this corresponded with an effectiveness of siRNA targeting ALK combined with the EGFR inhibitor gefitinib. Co-targeting EGFR and ALK decreased HNSCC cell number and colony formation ability and increased annexin V staining. Because ALK expression is low and ALK fusions are infrequent in HNSCC, we hypothesized that gefitinib treatment could induce ALK expression. We show that ALK expression was induced in HNSCC patient-derived cells both in 2D and 3D patient-derived cell culture models, and in patient-derived xenografts in mice. Four different ALK inhibitors, including two (ceritinib and brigatinib) FDA approved for lung cancer, were effective in combination with gefitinib. Together, we identified induction of ALK by EGFR inhibitor as a novel mechanism potentially relevant to resistance to EGFR inhibitor, a high ratio of response of HNSCC patient-derived tumor cells to a combination of ALK and EGFR inhibitors, and applicability of repurposing ALK inhibitors to HNSCC that lack ALK aberrations." @default.
• W2806193092 created "2018-06-13" @default.
• W2806193092 creator A5022461016 @default.
• W2806193092 creator A5032646570 @default.
• W2806193092 creator A5035335987 @default.
• W2806193092 creator A5035757557 @default.
• W2806193092 creator A5057525911 @default.
• W2806193092 creator A5058340446 @default.
• W2806193092 creator A5059664245 @default.
• W2806193092 creator A5066373576 @default.
• W2806193092 creator A5068500679 @default.
• W2806193092 creator A5070968397 @default.
• W2806193092 creator A5071117583 @default.
• W2806193092 creator A5078053382 @default.
• W2806193092 date "2018-08-17" @default.
• W2806193092 modified "2023-09-25" @default.
• W2806193092 title "Induction of anaplastic lymphoma kinase (ALK) as a novel mechanism of EGFR inhibitor resistance in head and neck squamous cell carcinoma patient-derived models" @default.
• W2806193092 cites W1485263743 @default.
• W2806193092 cites W1523413020 @default.
• W2806193092 cites W1974903221 @default.
• W2806193092 cites W1981989535 @default.
• W2806193092 cites W1982637165 @default.
• W2806193092 cites W1983499602 @default.
• W2806193092 cites W1986241711 @default.
• W2806193092 cites W1989223905 @default.
• W2806193092 cites W1990687470 @default.
• W2806193092 cites W1991590017 @default.
• W2806193092 cites W1996275566 @default.
• W2806193092 cites W2008922789 @default.
• W2806193092 cites W2010620134 @default.
• W2806193092 cites W2014639631 @default.
• W2806193092 cites W2018518196 @default.
• W2806193092 cites W2019443090 @default.
• W2806193092 cites W2024631759 @default.
• W2806193092 cites W2025717643 @default.
• W2806193092 cites W2026002143 @default.
• W2806193092 cites W2028151607 @default.
• W2806193092 cites W2038637004 @default.
• W2806193092 cites W2050249255 @default.
• W2806193092 cites W2051570504 @default.
• W2806193092 cites W2052705131 @default.
• W2806193092 cites W2053439872 @default.
• W2806193092 cites W2057906419 @default.
• W2806193092 cites W2072446111 @default.
• W2806193092 cites W2076011370 @default.
• W2806193092 cites W2080992857 @default.
• W2806193092 cites W2087032518 @default.
• W2806193092 cites W2096439168 @default.
• W2806193092 cites W2098480759 @default.
• W2806193092 cites W2099303768 @default.
• W2806193092 cites W2100235578 @default.
• W2806193092 cites W2100484302 @default.
• W2806193092 cites W2103110584 @default.
• W2806193092 cites W2104830962 @default.
• W2806193092 cites W2105341103 @default.
• W2806193092 cites W2108947370 @default.
• W2806193092 cites W2109399507 @default.
• W2806193092 cites W2112609258 @default.
• W2806193092 cites W2112910897 @default.
• W2806193092 cites W2120264635 @default.
• W2806193092 cites W2121635715 @default.
• W2806193092 cites W2124478432 @default.
• W2806193092 cites W2127280557 @default.
• W2806193092 cites W2146643228 @default.
• W2806193092 cites W2149441684 @default.
• W2806193092 cites W2149447281 @default.
• W2806193092 cites W2149584982 @default.
• W2806193092 cites W2153349010 @default.
• W2806193092 cites W2154889628 @default.
• W2806193092 cites W2167279371 @default.
• W2806193092 cites W2167690964 @default.
• W2806193092 cites W2170144893 @default.
• W2806193092 cites W2255416290 @default.
• W2806193092 cites W2345320779 @default.
• W2806193092 cites W2395228578 @default.
• W2806193092 cites W2467532605 @default.
• W2806193092 cites W2514723195 @default.
• W2806193092 cites W2593354385 @default.
• W2806193092 cites W2595645511 @default.
• W2806193092 cites W2758160475 @default.
• W2806193092 doi "https://doi.org/10.1080/15384047.2018.1451285" @default.
• W2806193092 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6300392" @default.
• W2806193092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29856687" @default.
• W2806193092 hasPublicationYear "2018" @default.
• W2806193092 type Work @default.
• W2806193092 sameAs 2806193092 @default.
• W2806193092 citedByCount "12" @default.
• W2806193092 countsByYear W28061930922019 @default.
• W2806193092 countsByYear W28061930922020 @default.
• W2806193092 countsByYear W28061930922021 @default.
• W2806193092 countsByYear W28061930922022 @default.
• W2806193092 countsByYear W28061930922023 @default.
• W2806193092 crossrefType "journal-article" @default.
• W2806193092 hasAuthorship W2806193092A5022461016 @default.
• W2806193092 hasAuthorship W2806193092A5032646570 @default.
• W2806193092 hasAuthorship W2806193092A5035335987 @default.
• W2806193092 hasAuthorship W2806193092A5035757557 @default.
• W2806193092 hasAuthorship W2806193092A5057525911 @default.

• next